• DOI:10.1001/JAMA.293.19.2372
Corpus ID: 30284439

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

@article{MosesKolko2005NeonatalSA,
  title={Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.},
  author={Eydie L. Moses-Kolko and D. Bogen and J. Perel and Amy J. Bregar and K. Uhl and B. Levin and K. Wisner},
  journal={JAMA},
  year={2005},
  volume={293 19},
  pages={
          2372-83
        }
}

Eydie L. Moses-Kolko, D. Bogen, +4 authors K. Wisner

Published 2005

Medicine

JAMA

CONTEXT A neonatal behavioral syndrome linked to in utero serotonin reuptake inhibitor (SRI) exposure during the last trimester of pregnancy has been identified. The US Food and Drug Administration (FDA) and drug manufacturers have recently agreed to a class labeling change for SRIs, which include selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs), to include information about potential adverse events in neonates exposed in utero… CONTINUE READING

View on PubMed

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed